InnovationRx is your weekly digest of healthcare news. Sign up!
Category: alexknappblog
This Company Aims To Bring Down The Cost Of Your Medicine With Price Transparency
Capital Rx’s new prescription drug card aims to compete with the likes of GoodRx.
Johnson & Johnson Executives Say Administration Of The Company’s Covid-19 Vaccine Will Resume Soon
Regulators in the EU and US meet this week to determine whether to resume administering the vaccine after reports of an extremely rare blood clotting side effect.
How The Johnson & Johnson Vaccine Pause Might Slow Down The Global Covid-19 Response
Richer countries have the luxury of picking and choosing between vaccine options, but their regulatory decisions may make it harder for poorer countries to fight the pandemic.
Federal Grand Jury Indicts uBiome Cofounders On Criminal Fraud Charges
On Thursday, a Federal grand jury indicted biotech startup uBiome’s cofounders Jessica Richman and Michael Apte with multiple charges related to defrauding insurance companies and investors.
SEC Charges Microbiome Startup uBiome’s Cofounders With Defrauding Investors For $60 Million
Jessica Richman and Zachary Apte were charged Thursday for failing to disclose significant issues related to the company’s insurance billing practices.
Lab Study Suggests Pfizer/BioNTech Vaccine Effective Against Variants After Second Dose
The lab study found a strong immune response to the U.K. and South African variants, with a ‘robust, but lower’ response to the South African variant.
Little-Known Publicly Traded Company Given Massive Deal To Manufacture One-Shot Covid-19 Vaccine
While Johnson & Johnson developed and got FDA authorization for its one-dose vaccine, it won’t be the one manufacturing it – that big task and huge windfall goes to a mostly unknown company in Maryland.
This Startup Just Raised $123 Million To Develop A New Way To Find Medicine
Cellarity aims to discover new therapies by looking at the impact of disease on the whole cell.
This College Professor Became An Overnight Billionaire Fighting Covid
Carl Hansen’s Abcellera Biologics scored big helping Eli Lilly develop antibodies to treat symptoms of Covid-19.
